Tierney David S's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Aug 23, 2024
- Accession no.
- 0001161697-24-000375
- Filed
- Aug 23, 2024
- Trade date
- Aug 21-22, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $301.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tierney David SCIK 0001292636 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +15,000 | $4.01 | +$60,150 | 363,874 | Direct | |
| Aug 21, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −15,000 | $20.10 | −$301,500 | 348,874 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $0.00 | $0 | 188,931 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.